Etravirine: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
==US Brand Names== | ==US Brand Names== | ||
'''INTELENCE'''<sup>®</sup> | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[Etravirine description|Description]]''' | ''' [[Etravirine description|Description]]''' | ||
Revision as of 15:36, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Category
Antiretroviral drug
US Brand Names
INTELENCE®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages